InvestorsHub Logo
Followers 70
Posts 1351
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Wednesday, 09/19/2018 8:03:39 PM

Wednesday, September 19, 2018 8:03:39 PM

Post# of 732701
Odds, very odds that anyone would believe the company would meet NICE date of submitting evidence support unless he or she believed the company had secretly unblinded data some months ago.

Com'on, sell your shares and move to other normal companies where no high IQs or common senses are required.

BTW, evidence support means unblinded data which would testify evidence of efficacy.

If the company decided to unblind data when last patient has been 36 months after surgery, one would expect two to three months at least to have the topline data ready, which means October or November this year (August + 2 or 3 months), or 36 months after enrollment, one would expect topline data in and around Jan or Feb 2019 (November + 2 or 3 months).

There might be some secret activities going on behind the scene, which are likely but not probable.

If there is still no dilution from the company or as long as no dilution from the company although it can do it readily thanks to all your generous yes votes, some positive things must have been happening:

The forced conversion is one; second, no pump but silence; third, no other trial launch distraction; ... which all mean confidence, and anytime you are in doubt, go read the blinded publication again!

In this stage and after the company has been unfairly assaulted from any angles in anyways, Linda ought to operate in stealth continually.

A surprise is for the good of patients and long suffering long investors, Linda, you must remember that.

With half of my family nets have parked with this company resulted from endless hours of DD, I am confident enough to continually add shares until after topline data is announced.

BTW, what's our MC? Slightly over 100 million? Wow, please sell.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News